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Background:  Osteoprotegerin (OPG) is a member of the tumor necrosis factor alpha receptor family and has recently emerged as key 
factor in atherosclerosis development. It is also associated with the development and extent of coronary artery disease (CAD). We evaluate 
the prognostic ability of serum OPG levels in patients with stable CAD after percutaneous coronary intervention (PCI).
methods:  We follow up prospectively (for a median time of 42months, range 5-52),146 consecutive subjects with stable CAD (mean age: 
62±9years) after successful PCI. Several demographic and clinical characteristics were collected. The primary end point was the composite 
of death from cardiovascular causes, nonfatal myocardial infarction, nonfatal stroke or hospitalization for cardiovascular causes. OPG 
levels were measured with ELISA
results:  During the follow-up period 44 subjects (30%) presented the primary composite endpoint. There was no difference in age 
(61±9years vs. 62±9years, p=0.56),serum creatinine levels (0.96±0.23mg/dl vs. 0.94±0.21, p=0.50), female gender (7% vs. 9%, p=0.68), 
in the prevalence of diabetes mellitus (30% vs. 19%, p=0.14),hypertension (87% vs. 80%, p=0.22) and in the smoking habits (23% vs. 
16%, p=0.30) between the subjects who presented the primary composite end point, compared to subjects free of cardiovascular events. 
Interestingly, subjects who presented the primary end point compared to those free of cardiovascular events had higher prevalence of 
3 vessel CAD (33% vs. 14%, p=0.05) and significantly increased OPG levels (4.21±2.19pmol/L vs. 3.12±1.74pmol/L, p=0.002). To take 
into account time dependency and to adjust for the aforementioned confounders we apply a cox regression model which revealed that 
the primary end point was significantly associated with OPG (Hazard ratio=1.23 95%CI: 1.039-1.45, p=0.02) even after adjustment for 
confounders such as age, sex, smoking habits, creatinine levels, extent of coronary artery disease, hypertension and diabetes mellitus.
Conclusion:  Serum osteoprotogerin level is a biomarker associated with arterial calcification and inflammation and can be used as a 
prognostic marker in patients with CAD after PCI.
